Karin Vanderkerken

Karin Vanderkerken publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Karin Vanderkerken sits on this spectrum.

Karin Vanderkerken D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Karin Vanderkerken sits on this spectrum.

Best Publications

• Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells.

  Jinheng Wang;Jinheng Wang;An Hendrix;Sophie Hernot;Miguel Lemaire

  476
  Citations

• Zoledronic Acid Treatment of 5T2MM‐Bearing Mice Inhibits the Development of Myeloma Bone Disease: Evidence for Decreased Osteolysis, Tumor Burden and Angiogenesis, and Increased Survival

  Peter I Croucher;Hendrik De Raeve;Mark J Perry;Anja Hijzen

  393
  Citations

• Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche.

  Michelle A Lawson;Michelle M McDonald;Michelle M McDonald;Natasa Kovacic;Weng Hua Khoo;Weng Hua Khoo

  383
  Citations

• Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features

  Abdel Kareem Azab;Jinsong Hu;Phong Quang;Feda Azab

  354
  Citations

• Cell biology of liver endothelial and Kupffer cells.

  B Smedsrød;P J De Bleser;F Braet;P Lovisetti

  298
  Citations

• Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma.

  Deborah J Heath;Andrew D Chantry;Clive H Buckle;Les Coulton

  294
  Citations

• Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.

  Karin Vanderkerken;Evy De Leenheer;Claire Shipman;Kewal Asosingh

  236
  Citations

• Liver cell heterogeneity: functions of non-parenchymal cells.

  Unknown

  192
  Citations

• Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug.

  Jinsong Hu;Jinsong Hu;Damian R Handisides;Els Van Valckenborgh;Hendrik De Raeve

  184
  Citations

• Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma.

  Michelle M. McDonald;Michelle M. McDonald;Michaela R. Reagan;Michaela R. Reagan;Scott E. Youlten;Scott E. Youlten;Sindhu T. Mohanty

  184
  Citations

• Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells.

  J. Caers;S. Deleu;Z. Belaid;H. De Raeve

  183
  Citations

• Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse

  K. Vanderkerken;H. De Raeve;E. Goes;S. Van Meirvenne

  174
  Citations

• In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2

  Ken Maes;Elizabeta Nemeth;G. David Roodman;Alissa Huston

  173
  Citations

• Multiple myeloma biology: lessons from the 5TMM models.

  Karin Vanderkerken;Kewal Asosingh;Peter Croucher;Ben Van Camp

  169
  Citations

• Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model

  Eline Menu;Helena Jernberg-Wiklund;Thomas Stromberg;Hendrik De Raeve

  168
  Citations

• Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3

  I Vande Broek;K Asosingh;K Vanderkerken;N Straetmans

  166
  Citations

• The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.

  Jinheng Wang;Kim De Veirman;Nathan De Beule;Ken Maes

  163
  Citations

• Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo.

  Andrew D Chantry;Debby Heath;Aaron W Mulivor;Scott Pearsall

  159
  Citations

• A novel therapeutic combination using PD 0332991 and bortezomib: study in the 5T33MM myeloma model.

  Eline Menu;Josefina Garcia;Xiangao Huang;Maurizio Di Liberto

  158
  Citations

• Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts.

  Sylvia Faict;Joséphine Muller;Kim De Veirman;Elke De Bruyne

  152
  Citations